V

Viela Bio

15 employees

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Autoimmunity
Research and Development
Health Diagnostics
Biotechnology
Innovative
Biologics
Wellness
Medical
Inflammation
Biopharma
Maryland

Date founded

2018

Funding rounds raised

Total raised

$282M

from 7 investors over 7 rounds

V

Viela Bio raised $75M on June 18, 2019

Investors: Temasek and Viking Global Investors

V

Viela Bio raised $282M on February 28, 2018

Investors: 6 Dimensions Capital, Sirona Capital, Temasek, Hillhouse Capital Management and Boyu Capital

FAQ